Newly Diagnosed Multiple Myeloma Recruiting Phase 2 Trials for Lenalidomide (DB00480)

Also known as: Newly Diagnosed Multiple Myeloma (NDMM) / Newly Diagnosed, Multiple Myeloma / Multiple Myeloma, Newly Diagnosed

IndicationStatusPhase
DBCOND0036257 (Newly Diagnosed Multiple Myeloma)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04891809Isatuximab in Combination With Rd Compared to Rd in Elderly Patients (Aged ≥70 Years) With NDMMTreatment
NCT04052880Study of SubQ Dara With Dose-Attenuated Bortezomib, Lenalidomide, Dexamethasone in Elderly NDMMTreatment